Is SNDX or SNSE more undervalued in 2026?

CirclFi compares Syndax Pharmaceuticals, Inc. (SNDX) and Sensei Biotherapeutics, Inc. (SNSE) using 13 institutional-grade valuation models. SNDX has a Quality of Company score of 5.7/10 while SNSE scores 3.7/10.

Which is a better buy — SNDX or SNSE?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do SNDX and SNSE valuations compare?

SNDX at $19.59 and SNSE at $21.14 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

SNDX vs SNSE Valuation Comparison 2026 — Intrinsic Value Analysis

SNDX

Pharmaceutical Preparations

Syndax Pharmaceuticals, Inc.

Quality

5.7

out of 10

Value Trap

LOW

Price

$19.59

Last close

Models

9/13

Active

SNSE

Pharmaceutical Preparations

Sensei Biotherapeutics, Inc.

Quality

3.7

out of 10

Value Trap

LOW

Price

$21.14

Last close

Models

5/13

Active

Model-by-Model Comparison

Model	Type	SNDX Fair Value	SNDX Upside	SNSE Fair Value	SNSE Upside
Bayesian DCF	Intrinsic	$1.11	-94.3%	$66.45	+214.3%
Earnings Power Value	Intrinsic	$2.58	-87.9%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$2.77	-85.9%	$1.33	-95.1%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for SNDX vs SNSE — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SNDX vs SNSE — Which Stock Is More Undervalued?

SNDX scores higher with a 5.7/10 quality rating vs SNSE's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Syndax Pharmaceuticals, Inc. (SNDX) and Sensei Biotherapeutics, Inc. (SNSE) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SNDX currently trades at $19.59 with a QOC of 5.7/10, while SNSE trades at $21.14 with a QOC of 3.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).